Skip to main content

PRELUDE CAPITAL MANAGEMENT, LLC

Position in EOLS — Evolus, Inc.

CIK 1387508 NEW YORK, NY

Position in EOLS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$210,855
-$50,509 QoQ
Shares Held
51,303
+30.5% QoQ
Ownership
0.078%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
6 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in EOLS Over Time

Shares Held

Position Value (USD)

Derivatives in EOLS

reported options exposure · as of Jun 30, 2020
CallValue
$2,120
CallShares
400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

PRELUDE CAPITAL MANAGEMENT, LLC holds $21,122,108 across 18 Drug Manufacturers - Specialty & Generic names. EOLS ranks #13 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in EOLS

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $210,855 51,303
2025-12-31 $261,364 39,303
2025-09-30 $216,539 35,267
2023-06-30 $117,206 16,122
2020-06-30 $2,120 400
2020-06-30 $1,060 200
2020-03-31 $830 200
2020-03-31 $4,980 1,200